Search

everythinglearnresearchcommunity

for

Search:↓

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

A new mouse model effectively mimics vitiligo for research and drug testing.

Balancing lipophilicity and solubility is key for effective and safe ketorolac prodrugs.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

A new peptide, murikal/SPR4, was found to significantly increase hair growth in mice, and its liposomal topical formulations enhanced hair growth more than commercial products. However, results on human scalp skin were unclear, needing more tests.

Two-photon microscopy improves skin imaging but faces safety and cost challenges for clinical use.

New psoriasis treatments are effective but come with side effects and risks.

Injectable cryogels can deliver drugs and aid tissue repair with minimal surgery.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Topical immunotherapy is the best treatment for severe alopecia areata.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Alopecia areata involves unique activation of certain immune cells.

Cubosomes enhance antimicrobial peptide stability and effectiveness.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.